TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
TRG |
|
T cell receptor gamma locus
|
|
|
0.631 |
0.538 |
MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
MIR150 |
|
microRNA 150
|
|
|
0.455 |
0.808 |
MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
ERVK-18 |
|
endogenous retrovirus group K member 18
|
|
|
0.560 |
0.654 |
ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
H3P9 |
|
H3 histone pseudogene 9
|
|
|
0.505 |
0.731 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
TRBV16 |
A0A087WV62
|
T cell receptor beta variable 16 (gene/pseudogene)
|
|
|
0.695 |
0.500 |
LGALS9 |
O00182
|
galectin 9
|
Signaling
|
6.5E-06 |
0.496 |
0.769 |
PIK3CD |
O00329
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
|
Kinase
|
1.00 |
0.319 |
0.885 |
CCL21 |
O00585
|
C-C motif chemokine ligand 21
|
Signaling
|
3.6E-02 |
0.502 |
0.769 |
CCL22 |
O00626
|
C-C motif chemokine ligand 22
|
Signaling
|
8.4E-03 |
0.500 |
0.846 |
IKBKB |
O14920
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
Kinase
|
0.99 |
0.506 |
0.846 |
MDM4 |
O15151
|
MDM4 regulator of p53
|
Nucleic acid binding
|
1.00 |
0.461 |
0.808 |
TP73 |
O15350
|
tumor protein p73
|
Transcription factor
|
1.00 |
0.449 |
0.808 |
BIRC5 |
O15392
|
baculoviral IAP repeat containing 5
|
Enzyme modulator
|
5.6E-02 |
0.495 |
0.731 |
CFLAR |
O15519
|
CASP8 and FADD like apoptosis regulator
|
Enzyme
|
1.00 |
0.485 |
0.846 |
SOCS1 |
O15524
|
suppressor of cytokine signaling 1
|
Enzyme modulator
|
0.59 |
0.445 |
0.808 |
DLEU1 |
O43261
|
deleted in lymphocytic leukemia 1
|
|
0.47 |
0.569 |
0.692 |
SUPT7L |
O94864
|
SPT7 like, STAGA complex subunit gamma
|
|
4.9E-02 |
0.890 |
0.115 |
TOX |
O94900
|
thymocyte selection associated high mobility group box
|
|
1.00 |
0.636 |
0.538 |
FOS |
P01100
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
Transcription factor
|
0.26 |
0.411 |
0.885 |